Abstracts of papers presented at the sixth meeting of the Nordic microcirculation group February 5–7 1976, Geilo, Norway
1976; Elsevier BV; Volume: 11; Issue: 3 Linguagem: Inglês
10.1016/0026-2862(76)90068-6
ISSN1095-9319
Tópico(s)Hemostasis and retained surgical items
ResumoAn interfacial cross-linking process was applied to hydrosoluble starch derivatives: hydroxyethylstarch (HES) and carboxymethylstarch (CMS). It resulted in stable microcapsules, which could be easily lyophilized and gave free-flowing powders. Sodium salicylate was encapsulated in HES microcapsules. In vitro dissolution studies indicated that these walls allow a prolonged release of the tracer. CMS microcapsules exhibited hydrophilic properties, as shown by water-induced swelling and gel formation. All cross-linked polysaccharide microcapsules were characterized by a total resistance to digestive media. However, when a protein, human serum albumin (HSA) or gelatin, was added to the starch derivatives in the aqueous phase, the process provided biodegradable microcapsules.
Referência(s)